SCHEMBL6202420

SCHEMBL6202420

CCCCCc1cc(OC)c2cc(NC(C)=O)ccc2n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 9/20 0.54
ELANE P08246 1/20 0.47
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
ALDH1A1 P00352 2/20 0.46
MAPT P10636 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
KDM4E B2RXH2 2/20 0.46
HPGD P15428 1/20 0.46
GAA P10253 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
APAF1 O14727 1/20 0.44
TDP2 O95551 1/20 0.44
MAPK1 P28482 1/20 0.44
CASP3 P42574 1/20 0.44
SENP8 Q96LD8 1/20 0.44
HSD17B10 Q99714 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
RAB9A P51151 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4259484 0.92 MCHR1 (0.62) MCHR1ELANEMEN1KMT2AALDH1A1
SCHEMBL6203236 0.85 MCHR1 (0.49) MCHR1ELANEMEN1KMT2AMAPT
SCHEMBL6199601 0.84 MCHR1 (0.63) MCHR1
SCHEMBL31672140 0.78 DOT1L (0.57) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL3738216 0.78 DOT1L (0.57) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL4269277 0.76 MCHR1 (0.53) MCHR1ELANESMN1; SMN2GAARAB9A
SCHEMBL31587738 0.75 ESR1 (0.58) MCHR1MEN1KMT2AALDH1A1MAPT
SCHEMBL951984 0.75 LMNA (0.55) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL4258680 0.75 MCHR1 (0.70) MCHR1
SCHEMBL10949246 0.75 MEN1 (0.47) MEN1KMT2AALDH1A1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1451156-A4 4-AMINOQUINOLINE COMPOUNDS MERCK & CO INC (US) 2005-05-25 EP disclosed
US-20050009815-A1 4-Aminoquinoline compounds DEVITA ROBERT J (US) 2005-01-13 US disclosed
EP-1451156-A1 4-AMINOQUINOLINE COMPOUNDS Merck & Co., Inc. (US) 2004-09-01 EP disclosed
WO-2003045920-A1 4-AMINOQUINOLINE COMPOUNDS MERCK & CO., INC. (US) 2003-06-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009815-A1 4-Aminoquinoline compounds MCHR1, MCHR2, MC5R MCHR1 1/4885ELANE 4614/4885MEN1 491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.